NCT06804096View on ClinicalTrials.gov

Efficacy and Safety of Faropenem in Bangladeshi Adult Patients With Community-Acquired Bacterial Pneumonia (CABP)

PHASE4RecruitingINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

February 20, 2025

Primary Completion Date

September 30, 2025

Study Completion Date

December 1, 2025

Conditions
Pneumonia, Community-AcquiredBacterial Pneumonia
Interventions
DRUG

Faropenem

Tab. Faropenem 200mg three times daily

DRUG

Co-amoxiclav

Tab. Co-Amoxiclav 625mg three times daily

DRUG

Clarithromycin 500 mg

Tab. Clarithromycin 500mg two times daily

Trial Locations (2)

1205

RECRUITING

Popular Medical College & Hospital, Dhaka

RECRUITING

Shaheed Suhrawardy Medical College & Hospital, Dhaka

All Listed Sponsors
lead

Dr. Md. Alimur Reza

INDUSTRY